Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 12,655 | 10,972 | 11,271 | 28,316 | 9,548 |
| Operating Income | -12,655 | -10,972 | -11,271 | -28,316 | -9,548 |
| Other Income | 115 | -78 | 153 | 221 | 75 |
| Pre-tax Income | -12,540 | -11,050 | -11,118 | -28,095 | -9,473 |
| Net Income Continuous | -12,540 | -11,050 | -11,118 | -28,095 | -9,473 |
| Net Income | $-12,540 | $-11,050 | $-11,118 | $-28,095 | $-9,473 |
| EPS Basic Total Ops | -0.53 | -0.47 | 10.43 | -1.55 | -7.57 |
| EPS Basic Continuous Ops | -0.53 | -0.47 | 10.43 | -1.55 | -7.57 |
| EPS Diluted Total Ops | -0.53 | -0.47 | 10.43 | -1.55 | -7.57 |
| EPS Diluted Continuous Ops | -0.53 | -0.47 | 10.43 | -1.55 | -7.57 |
| EBITDA(a) | $-12,430 | $-10,756 | $-11,011 | $-28,052 | $-9,557 |